CDKN2A and cancer: Cyclin-dependent kinase inhibitor 2A (CDKN2A) encodes and results in a production of p16 genes that are involved with a range of cellular pathways which consists of suppression of the cancer cell cycle, cell senescence, apoptosis, differentiation, and DNA repair [8,9].